These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 26035747)

  • 21. Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer.
    Gyawali B; Ota A; Ando Y
    N Engl J Med; 2016 Feb; 374(5):493. PubMed ID: 26840146
    [No Abstract]   [Full Text] [Related]  

  • 22. Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer.
    Hasegawa T; Uno H; Wei LJ
    N Engl J Med; 2016 Feb; 374(5):492-3. PubMed ID: 26840145
    [No Abstract]   [Full Text] [Related]  

  • 23. Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer.
    Borghaei H; Brahmer J
    N Engl J Med; 2016 Feb; 374(5):493-4. PubMed ID: 26840144
    [No Abstract]   [Full Text] [Related]  

  • 24. Nivolumab in Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer With Squamous-Cell Histology: A Perspective Based on Pharmacologic Costs.
    Giuliani J; Bonetti A
    Clin Lung Cancer; 2017 Sep; 18(5):e363-e365. PubMed ID: 28502555
    [No Abstract]   [Full Text] [Related]  

  • 25. Cetuximab in advanced non-small cell lung cancer.
    Govindan R
    Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4241s-4244s. PubMed ID: 15217966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeting the epidermal growth factor receptor a new strategy in cancer treatment.
    Gianni L; Grasselli G
    Suppl Tumori; 2002; 1(4):S60-1. PubMed ID: 12415824
    [No Abstract]   [Full Text] [Related]  

  • 27. Developing targeted therapies for lung cancer.
    Gandara DR
    Clin Adv Hematol Oncol; 2003 Nov; 1(11):648-9, 690. PubMed ID: 16258461
    [No Abstract]   [Full Text] [Related]  

  • 28. Nivolumab for Metastatic Melanoma.
    Gupta AK; Daigle D
    Skin Therapy Lett; 2016 Mar; 21(2):6-9. PubMed ID: 27223114
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Editorial: Comparative efficacy and cost associated with new agents in the treatment of non-small cell lung cancer (NSCLC).
    Mueller E
    Lung Cancer; 2010 Aug; 69 Suppl 1():S1-3. PubMed ID: 20727456
    [No Abstract]   [Full Text] [Related]  

  • 30. Is there a role for cetuximab in non small cell lung cancer?
    Morgensztern D; Govindan R
    Clin Cancer Res; 2007 Aug; 13(15 Pt 2):s4602-5. PubMed ID: 17671149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nivolumab Enhances the Inflammation of the Irradiation Field in Advanced Non-Small Cell Lung Cancer.
    Furuta H; Yoshida T; Shimizu J; Tomita N; Yatabe Y; Hida T
    J Thorac Oncol; 2017 Nov; 12(11):1733-1736. PubMed ID: 28774862
    [No Abstract]   [Full Text] [Related]  

  • 32. Nivolumab for advanced squamous cell lung cancer: what are the next steps?
    de Mello RA; Pousa I; Pereira D
    Lancet Oncol; 2015 Mar; 16(3):234-5. PubMed ID: 25704436
    [No Abstract]   [Full Text] [Related]  

  • 33. Prior radiotherapy does not predict nivolumab response in non-small-cell lung cancer: a retrospective cohort study.
    Kataoka Y; Ebi N; Fujimoto D; Hara S; Hirano K; Narabayashi T; Tanaka T; Tomii K; Yoshioka H
    Ann Oncol; 2017 Jun; 28(6):1402. PubMed ID: 28368440
    [No Abstract]   [Full Text] [Related]  

  • 34. Monoclonal antibodies against EGFR in non-small cell lung cancer.
    Pirker R; Filipits M
    Crit Rev Oncol Hematol; 2011 Oct; 80(1):1-9. PubMed ID: 21109448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IASLC 2019 World Conference on Lung Cancer.
    Venkatesan P
    Lancet Respir Med; 2019 Nov; 7(11):930-932. PubMed ID: 31548107
    [No Abstract]   [Full Text] [Related]  

  • 36. Perspectives in Lung Cancer--Third Asian-pacific Conference. 11-12 September 2009, Bangkok, Thailand.
    Lopes Gde L
    IDrugs; 2009 Nov; 12(11):689-91. PubMed ID: 19844853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ramucirumab combination improves OS and PFS in NSCLC.
    Izzo C
    Am J Manag Care; 2014 Mar; 20(5 Spec No.):E9. PubMed ID: 25618624
    [No Abstract]   [Full Text] [Related]  

  • 38. Treatment of non-small-cell lung cancer: state of the art and development of new biologic agents.
    Gridelli C; Rossi A; Maione P
    Oncogene; 2003 Sep; 22(42):6629-38. PubMed ID: 14528288
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Personalized, targeted treatment of non-small cell lung cancer].
    Wolf J
    Dtsch Med Wochenschr; 2011 Mar; 136(10):480-5. PubMed ID: 21365525
    [No Abstract]   [Full Text] [Related]  

  • 40. Unanswered questions: monoclonal antibodies in the treatment of advanced non-small-cell lung cancer.
    Gridelli C; Rossi A
    Oncology (Williston Park); 2010 Nov; 24(13):1216-23. PubMed ID: 21192561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.